Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase β-TrCP

Area of Science:

• Virology
• Molecular Biology
• Cellular Signaling

Background:

• Vaccinia virus (VACV) utilizes multiple proteins to disrupt host cell NF-κB signaling.
• The VACV protein A49 specifically targets the E3 ubiquitin ligase β-transducin repeat-containing protein 1 (β-TrCP).
• β-TrCP is crucial for degrading IκBα, thereby regulating NF-κB pathway activation, and also targets other substrates like β-catenin.

Purpose of the Study:

• To investigate the effect of VACV protein A49 on the Wnt signaling pathway.
• To determine if A49's interaction with β-TrCP influences Wnt pathway activation.
• To elucidate the broader impact of A49 on cellular signaling cascades.

Main Methods:

• Ectopic expression of A49 in cells.
• VACV infection of cells.
• Analysis of β-catenin and IκBα protein levels.
• Assessment of Wnt signaling pathway activation.
• Mutational analysis to assess the role of β-TrCP binding.

Main Results:

• Ectopic expression or VACV infection with A49 leads to the accumulation of β-catenin.
• A49-mediated activation of the Wnt pathway is dependent on its binding to β-TrCP.
• A49 inhibits the ubiquitylation and degradation of both IκBα and β-catenin by β-TrCP.
• These findings suggest A49 broadly interferes with β-TrCP function.

Conclusions:

• VACV protein A49 activates the Wnt signaling pathway.
• A49's activation of Wnt signaling is mediated through its interaction with β-TrCP.
• A49's targeting of β-TrCP impacts multiple cellular pathways, including NF-κB and Wnt signaling, highlighting its role in viral immune evasion and host manipulation.